ArticleCancer medicine2023

Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinoma.

Yumei Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.